Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risperidone

L J Cohen1

  • 1College of Pharmacy, University of Oklahoma, Oklahoma City 73190.

Pharmacotherapy
|May 1, 1994
PubMed
Summary
This summary is machine-generated.

Risperidone, a novel antipsychotic, effectively treats schizophrenia

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A simple technique for the single-handed management of anterior epistaxis.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2016
Same author

A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493), a folate receptor targeted chemotherapeutic agent in humans with advanced solid tumors.

Investigational new drugs·2014
Same author

Chorionepithelioma.

United States naval medical bulletin·2010
Same author

Personality measures in former heroin users receiving methadone or in protracted abstinence from opiates.

Acta psychiatrica Scandinavica·2005
Same author

Docetaxel and cisplatin in patients with advanced non small-cell lung cancer (NSCLC): a multicenter phase II trial.

Clinical lung cancer·2004
Same author

Synergistic antiviral effect of PEG-asparaginase (ONCASPAR), with protease inhibitor alone and in combination with RT inhibitors against HIV-1 infected T-cells: a model of HIV-1-induced T-cell lymphoma.

In vivo (Athens, Greece)·2001
Same journal

The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers.

Pharmacotherapy·2026
Same journal

Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.

Pharmacotherapy·2026
Same journal

Getting It Right the Second Time: How Can we Optimize First-Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?

Pharmacotherapy·2026
Same journal

Buprenorphine Initiation During Extracorporeal Membrane Oxygenation Decreases Sedative and Opioid Exposure: A Retrospective Matched Case-Control Study.

Pharmacotherapy·2026
Same journal

Voriconazole Dosing and Therapeutic Drug Monitoring in Patients Before and After Liver Transplantation.

Pharmacotherapy·2026
Same journal

Quantifying the Serum Magnesium Response and Predictors of Response Following Intravenous Magnesium Replacement in Critically Ill Patients.

Pharmacotherapy·2026
See all related articles

Area of Science:

  • Pharmacology
  • Neuroscience
  • Psychiatry

Background:

  • Risperidone is a benzisoxazole derivative with high affinity for serotonin 5-HT2 and dopamine D2 receptors.
  • Its metabolite, 9-hydroxyrisperidone, shares similar pharmacologic activity, forming the active antipsychotic moiety.
  • Compared to haloperidol, risperidone exhibits significantly higher serotonin receptor affinity.

Purpose of the Study:

  • To evaluate the efficacy of risperidone in treating schizophrenia.
  • To assess the side effect profile of risperidone, particularly extrapyramidal symptoms.
  • To position risperidone as an advancement in psychosis treatment.

Main Methods:

  • Clinical trials were conducted to assess risperidone's effectiveness.
  • Pharmacologic binding affinities for various receptors were determined.

Related Experiment Videos

  • Comparative analysis with haloperidol was performed.

    • Main Results:

    • Risperidone demonstrated efficacy in improving both positive and negative symptoms of schizophrenia.
    • The drug's affinity for serotonin receptors is substantially greater than haloperidol's.
    • Extrapyramidal side effects at recommended dosages were comparable to placebo.

    Conclusions:

    • Risperidone is an effective antipsychotic agent for schizophrenia treatment.
    • The favorable side effect profile suggests improved tolerability.
    • Risperidone represents a significant advancement in managing psychotic disorders.